About Chugai
Chugai's mission is to create innovative drugs
for the benefit of patients.
News ReleasesRSS
- Feb 13, 2019 Chugai’s Actemra, the World’s First Anti-IL-6 Receptor Antibody Created in Japan, Wins Chairman’s Award of Japan Techno-Economics Society
- Feb 12, 2019 Chugai Wins Second Prize in 21st NIKKEI Annual Report Awards
- Feb 06, 2019 Together with Roche, Chugai Joins the World Federation of Hemophilia Humanitarian Aid Program
- Feb 05, 2019 The 1st Japan Open Innovation Prize: Four Parties including Osaka University Win the Minister of Education, Culture, Sports, Science and Technology Award for “University-Industry Co-creation from the Basic Research Stage -Collaboration between Organizations-”
- Feb 04, 2019 Chugai’s Hemlibra® Gains Positive CHMP Opinion in Severe Hemophilia A without Inhibitors
-
Diversity and Inclusion Initiatives
Find information on our initiatives to promote work-life balance and diverse human resources, and performance data for topics such as the ratio of female employees.
-
Engagement with Employees
Chugai promotes engagement with employees by conducting talent management according to each person's capabilities and aptitude, providing systems that help our diverse people to succeed, and creating supportive work environments.
